Senores Pharmaceuticals Limited has informed the Exchange about submission of Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2025 under SEBI (Depositories and Participants) Regulations, 2018
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted its quarterly Reconciliation of Share Capital Audit Report to the Exchange for the quarter ended March 31, 2025. This report is filed under SEBI's Depositories and Participants Regulations, 2018, and is a standard regulatory requirement for all listed companies. The audit reconciles the company's total share capital held in physical form with that held in dematerialized (demat) form across the NSDL and CDSL depositories. The filing confirms compliance with listing norms and is submitted by the company's qualified Practicing Company Secretary (PCS).
This is a routine compliance filing with no material impact on the stock price or shareholder value. Investors can take it as confirmation that the company is meeting its quarterly disclosure obligations regarding share capital records.